We are aware of current issues with the ONS login. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy
Elisa Becze, BA, ELS, Editor
Voice
Description
Combination treatment with an oncolytic virus plus a PD-1 inhibitor shows promise in patients with nonmelanoma skin cancers, researchers reported in early study results during the 2022 Multidisciplinary Head and Neck Cancers Symposium.